Bio-Rad Laboratories (BIO) Retained Earnings (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Retained Earnings of $490.5 million for Q1 2026, down 93.44% year-over-year from $7.5 billion in Q1 2025, and down 94.0% quarter-over-quarter from $8.2 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Retained Earnings (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Retained Earnings for 18 consecutive years, with $490.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 93.44% year-over-year to $490.5 million; the TTM figure through Mar 2026 stood at $490.5 million (down 93.44% YoY), while the FY2025 annual figure was $8.2 billion, up 1665.18% from the prior year.
- Retained Earnings declined to $490.5 million in Q1 2026 per BIO's latest filing, from $8.2 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $9.6 billion in Q1 2024 and bottomed at -$845.2 million in Q3 2022.
- Historically, Retained Earnings has averaged $1.8 billion across 5 years, with a median of $9.9 million in 2023.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 6418.29% — and 2024, when it surged 95390.54%.
- Bio-Rad Laboratories' Retained Earnings stood at -$10.3 million in 2022, then jumped by 4460.19% to $449.1 million in 2023, then climbed by 3.14% to $463.2 million in 2024, then soared by 1665.18% to $8.2 billion in 2025, then tumbled by 94.0% to $490.5 million in 2026.
- Business Quant data shows BIO's Retained Earnings at $490.5 million in Q1 2026, $8.2 billion in Q4 2025, and $7.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 8.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.02 Bn |
| Mar 31, 2026 | 490.50 Mn |
| Dec 31, 2025 | 8.18 Bn |
| Sep 30, 2025 | 7.46 Bn |
| Jun 30, 2025 | -154.10 Mn |
| Mar 31, 2025 | 7.48 Bn |
| Dec 31, 2024 | 463.20 Mn |
| Sep 30, 2024 | -315.27 Mn |
| Jun 30, 2024 | -451.36 Mn |
| Mar 31, 2024 | 9.64 Bn |
| Dec 31, 2023 | 449.10 Mn |
| Sep 30, 2023 | 9.90 Mn |
| Jun 30, 2023 | -374.70 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | -10.30 Mn |
| Sep 30, 2022 | -845.20 Mn |
| Jun 30, 2022 | -518.10 Mn |
| Mar 31, 2022 | -307.90 Mn |
| Dec 31, 2021 | -175.60 Mn |
| Sep 30, 2021 | -22.20 Mn |